Clinical trials demonstrated average weight reductions of 15-21% of body weight over 72 weeks in people with obesity (SURMOUNT-1), while more modest weight loss was observed in type 2 diabetes patients (SURPASS trials)
Unlike MOTS-c or Semax, which use spaced or cycling injection schedules to prevent receptor desensitization, Epithalon is designed as a short, continuous burst protocol
Small donor group for ex vivo work
This improvement was correlated with increased protein levels of testosterone synthesis-related enzymes, 3-HSD and CYP11A1, in the testes of treated aged mice
Medical Supervision Recommended Because peptides can affect metabolic processes, consulting a healthcare professional is recommended before considering their use
Other Tissue Effects Beyond skin and hair, GHK-Cu supports broader tissue healing